LLY
Eli Lilly and Company
Company Overview
| Mkt Cap | $788.86B | Price | $897.41 |
| Volume | 3.54M | Change | +4.00% |
| P/E Ratio | 74.5 | Open | $866.53 |
| Revenue | $45.0B | Prev Close | $862.86 |
| Net Income | $10.6B | 52W Range | $623.78 - $935.63 |
| Div Yield | 6.00% | Target | $925.50 |
| Overall | 61 | Value | 25 |
| Quality | 68 | Technical | 90 |
No chart data available
Stock Overview
Updated DailyEli Lilly and Company (LLY) is a leading Healthcare company in the Drug Manufacturers - Major industry, currently trading at $862.86 with a market capitalization of $788.86 billion. The stock is positioned in the upper portion of its trading range, demonstrating solid quality metrics with a MarketXLS quality score of 68.
Today's trading session shows LLY with a volume of 5.02 million shares. The stock opened down 0.63% from yesterday's close of $844.50. Current analyst estimates project earnings of $22.73 per share for this year, with next year targeting $30.78.
LLY demonstrates very strong technical momentum based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including BMY, MRK, JNJ, PFE, SNY.
Key investment considerations for LLY include solid overall investment characteristics. The company offers a dividend yield of 6% and analyst price targets suggest potential upside of 7.3%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 08:12 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LLY | $897.41 | +4.0% | 3.54M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |